xiaofeng zeng
Peking Union Medical College Hospital
10
10
6
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+6 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (10)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Rui Chen
Peking Union Medical College Hospital
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Alan Kivitz, MD
Altoona Center for Clinical Research
Shared therapeutic areas:
Bradley Schoch, MD
Mayo Clinic
Shared therapeutic areas:
Mustafa H Temel, M.D.
Uskudar State Hospital
Shared therapeutic areas:
Xianyun Wang, Doctor
The First Hospital of Hebei Medical University
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Hillary Overholser
Zimmer Biomet
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (10)
Showing 10 of 10 trials
JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus
Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients
A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis
Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients
Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
All 10 trials loaded